{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T02:15:22Z","timestamp":1788142522848,"version":"build-2803163510"},"reference-count":66,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Int Assoc Provid AIDS Care"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Long-acting injectable antiretroviral therapy (LAI-ART), especially cabotegravir plus rilpivirine, is primarily recommended as a switch option for virally suppressed individuals and may improve adherence, privacy, and treatment satisfaction. Contemporary international guidance notes a restricted, closely monitored role for selected viraemic patients with persistent adherence challenges. Feasibility in low-resource systems remains uncertain. We explored perceived feasibility and acceptability of LAI-ART among HIV care providers and regulatory stakeholders in Pakistan.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted semistructured in-depth interviews with 17 providers and stakeholders from ART centers, tertiary hospitals, the National AIDS Control Program, and a community-based organization in Islamabad and Rawalpindi. Interviews were audio recorded, transcribed, translated, and analyzed using reflexive thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants viewed LAI-ART as promising for improving adherence, treatment fatigue, confidentiality, and workflow. Barriers included travel distance, needle phobia, missed dose risks, staffing constraints, cold chain and storage needs, infrastructure limitations, and weak biomedical waste management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Stakeholders expressed cautious interest in LAI-ART while highlighting significant structural, financial, and sociocultural barriers. Participants emphasized that phased pilot implementation, sustainable financing, cultural acceptability, integration into differentiated service delivery, and stronger counselling and digital support would be necessary to support future introduction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/23259582261452317","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:23:39Z","timestamp":1779200619000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Feasibility and Implementation Considerations for Long-Acting Antiretroviral Therapy in Pakistan: A Qualitative Study of Healthcare Providers and Programmatic Stakeholders"],"prefix":"10.1177","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4134-1956","authenticated-orcid":false,"given":"Muhammad Wasay","family":"Shahid","sequence":"first","affiliation":[{"name":"Riphah International University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Masood-ur-Rehman","sequence":"additional","affiliation":[{"name":"Riphah International University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-2394-0959","authenticated-orcid":false,"given":"Faizur","family":"Rehman","sequence":"additional","affiliation":[{"name":"Riphah International University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8533-1339","authenticated-orcid":false,"given":"Mehran","family":"Riaz","sequence":"additional","affiliation":[{"name":"Riphah International University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Aaqib","family":"Akram","sequence":"additional","affiliation":[{"name":"Al-Hamad Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-8353-8726","authenticated-orcid":false,"given":"Farah","family":"Azhar","sequence":"additional","affiliation":[{"name":"Riphah International University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-1287-3606","authenticated-orcid":false,"given":"Malik Muhammad","family":"Umair","sequence":"additional","affiliation":[{"name":"National AIDS Control Program, Common Management Unit"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5344-2027","authenticated-orcid":false,"given":"Nasim","family":"Akhtar","sequence":"additional","affiliation":[{"name":"Pakistan Institute of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Musarat","family":"Jabeen","sequence":"additional","affiliation":[{"name":"Pakistan Institute of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8964-1853","authenticated-orcid":false,"given":"Ali","family":"Ahmed","sequence":"additional","affiliation":[{"name":"School of Medicine, University of California San Diego (UCSD)"},{"name":"Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1097\/qad.0000000000003102"},{"key":"e_1_3_3_3_2","unstructured":"Rana AI Bao Y Zheng L et al. Long-acting injectable CAB\/RPV is superior to oral ART in PWH with adherence challenges: ACTG A5359. Conference on Retroviruses and Opportunistic Infections (CROI). March 3-6 2024 2024; Special Session: Clinical Late-Breaking Oral Abstracts."},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2020.1764906"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1177\/23259582211009011"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/coh.0000000000000708"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1909512"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/s2666-5247(22)00009-x"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26126"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262926"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0319010"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-10352-w"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2023.2253506"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaf192"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1186\/s43058-023-00506-3"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-06214-9"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac752"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2022.100603"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.5495\/wjcid.v14.i2.109220"},{"key":"e_1_3_3_20_2","unstructured":"NACP. Current statistics. Accessed December 12th 2025. https:\/\/www.cmu.gov.pk\/nacp-national-aids-control-programme\/."},{"key":"e_1_3_3_21_2","first-page":"102","volume-title":"Building HIV Care Capacity in Pakistan: \u201cLeveraging Insights From A Joint US-Pakistani Project\u201d","author":"Gillani FS","year":"2025","unstructured":"Gillani FS. HIV treatment in Pakistan: Clinical practice, challenges and evolving therapies. In: Building HIV Care Capacity in Pakistan: \u201cLeveraging Insights From A Joint US-Pakistani Project\u201d. US Books Publisher; 2025:102."},{"key":"e_1_3_3_22_2","unstructured":"UNAIDS. Country factsheets: Pakistan 2024. 2025. Accessed October 19 2025. https:\/\/www.unaids.org\/en\/regionscountries\/countries\/pakistan."},{"key":"e_1_3_3_23_2","unstructured":"UNAIDS. Country factsheets Pakistan | 2023. 2023. Accessed September 28 2024. https:\/\/www.unaids.org\/en\/regionscountries\/countries\/pakistan."},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.745545"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.807446"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae557"},{"key":"e_1_3_3_27_2","unstructured":"World Health Organization. Overview of WHO recommendations on HIV and sexually transmitted infection testing prevention treatment care and service delivery. 2025."},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.24543"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2023.0248"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2020.0126"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1080\/25787489.2026.2635223"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-021-02771-y"},{"key":"e_1_3_3_33_2","unstructured":"NACP. HIV treatment services. Accessed December 12th 2025. https:\/\/www.cmu.gov.pk\/nacp-national-aids-control-programme\/nacp-national-aids-control-programme-treatment\/."},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1089\/aid.2024.0117"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-017-2442-6"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11135-021-01182-y"},{"key":"e_1_3_3_37_2","first-page":"82","volume-title":"Building HIV Care Capacity in Pakistan: \u201cLeveraging Insights from a Joint US-Pakistani Project\u201d","author":"Gillani FS","year":"2025","unstructured":"Gillani FS. HIV testing in Pakistan, breaking barriers and advancing early diagnosis. In: Building HIV Care Capacity in Pakistan: \u201cLeveraging Insights from a Joint US-Pakistani Project\u201d. US Books Publisher; 2025:82."},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09748-5"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1518719"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2023.0017"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0234666"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/coh.0000000000000732"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(21)00025-5"},{"key":"e_1_3_3_44_2","first-page":"249","volume-title":"Building HIV Care Capacity in Pakistan: \u201cLeveraging Insights from a Joint US-Pakistani Project\u201d","author":"Gillani FS","year":"2025","unstructured":"Gillani FS. Iatrogenic HIV transmission in Pakistan: Unsafe injections, blood transfusions, and infection control failure. In: Building HIV Care Capacity in Pakistan: \u201cLeveraging Insights from a Joint US-Pakistani Project\u201d. US Books Publisher; 2025:249\u2013252."},{"issue":"4","key":"e_1_3_3_45_2","article-title":"Understanding HIV outbreak among children in a rural community of Sindh province of Pakistan","volume":"71","author":"Altaf A","year":"2021","unstructured":"Altaf A, Shah SA, Khanani R, Vermund SH. Understanding HIV outbreak among children in a rural community of Sindh province of Pakistan. J Pak Med Assoc. 2021;71(Suppl 4)(8):S1\u2013S4.","journal-title":"J Pak Med Assoc"},{"key":"e_1_3_3_46_2","unstructured":"DAWN. HIV spread in Taunsa: Joint mission discusses preventive measures. Accessed June 8 2025. https:\/\/www.dawn.com\/news\/1903627\/hiv-spread-in-taunsa-joint-mission-discusses-preventive-measures."},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1080\/09540121.2025.2532600"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.26095"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1111\/hiv.13370"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciac631"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.7326\/m23-0788"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciae500"},{"key":"e_1_3_3_53_2","unstructured":"NIH. What's New: Adult and adolescent ARV HIV clinical guidelines. Accessed April 14th 2026. https:\/\/clinicalinfo.hiv.gov\/en\/guidelines\/hiv-clinical-guidelines-adult-and-adolescent-arv\/whats-new."},{"key":"e_1_3_3_54_2","unstructured":"Cabenuva. What is CABENUVA? Accessed July 10th 2025. https:\/\/www.cabenuva.com\/about\/what-is-cabenuva\/."},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid3008.240019"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.703631"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2012.0585"},{"key":"e_1_3_3_58_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-018-3744-z"},{"key":"e_1_3_3_59_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2022.0192"},{"key":"e_1_3_3_60_2","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11172453"},{"key":"e_1_3_3_61_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05571-w"},{"key":"e_1_3_3_62_2","first-page":"2025","volume-title":"Fundamentals of HIV Medicine","author":"Cocohoba J","year":"2025","unstructured":"Cocohoba J. The pharmacist\u2019s role in HIV care. In: Fundamentals of HIV Medicine. Oxford University Press; 2025:2025."},{"key":"e_1_3_3_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rcsop.2021.100066"},{"key":"e_1_3_3_64_2","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2023.0250"},{"key":"e_1_3_3_65_2","unstructured":"American Society of Health-System Pharmacists (ASHP). Draft 2025 ASHP guidelines on pharmacist involvement in HIV care. ASHP. Accessed December 8 2025. https:\/\/www.ashp.org\/-\/media\/assets\/policy-guidelines\/docs\/guidelines\/pharmacist-involvement-hiv-care.ashx."},{"key":"e_1_3_3_66_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-025-12971-8"},{"key":"e_1_3_3_67_2","unstructured":"UNAIDS. An evaluation of the contribution of the UNAIDS joint programme to strengthening HIV and primary health care outcomes | Pakistan report. 2023. Accessed December 8 2025. https:\/\/www.unaids.org\/sites\/default\/files\/media\/documents\/pakistan-evaluation-hiv-primary-health-care_en.pdf."}],"container-title":["Journal of the International Association of Providers of AIDS Care (JIAPAC)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23259582261452317","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23259582261452317","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23259582261452317","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T01:25:54Z","timestamp":1788139554000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/23259582261452317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":66,"alternative-id":["10.1177\/23259582261452317"],"URL":"https:\/\/doi.org\/10.1177\/23259582261452317","relation":{},"ISSN":["2325-9582","2325-9582"],"issn-type":[{"value":"2325-9582","type":"print"},{"value":"2325-9582","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"article-number":"23259582261452317"}}